Cargando…
“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction
C-reactive protein (CRP) may be causative in cardiovascular disease. As yet, no specific CRP inhibitor for human application has been described. A 69-year-old male was referred with ST segment elevation myocardial infarction (STEMI). Typical symptoms of chest pain started at 10.00 p.m. The patient w...
Autores principales: | Ries, Wolfgang, Sheriff, Ahmed, Heigl, Franz, Zimmermann, Oliver, Garlichs, Christoph D., Torzewski, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247695/ https://www.ncbi.nlm.nih.gov/pubmed/30533227 http://dx.doi.org/10.1155/2018/4767105 |
Ejemplares similares
-
Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study
por: Skarabis, Horst, et al.
Publicado: (2022) -
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons
por: Torzewski, Jan, et al.
Publicado: (2022) -
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
por: Ries, Wolfgang, et al.
Publicado: (2021) -
First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection
por: Torzewski, Jan, et al.
Publicado: (2020) -
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis
por: Torzewski, Jan, et al.
Publicado: (2021)